Literature DB >> 25446259

The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer.

Jordan A Beard1, Alexa Tenga1, Taosheng Chen2.   

Abstract

Nuclear receptor (NR) subfamily 4 group A (NR4A) is a family of three highly homologous orphan nuclear receptors that have multiple physiological and pathological roles, including some in cancer. These NRs are reportedly dysregulated in multiple cancer types, with many studies demonstrating pro-oncogenic roles for NR4A1 (Nur77) and NR4A2 (Nurr1). Additionally, NR4A1 and NR4A3 (Nor-1) are described as tumor suppressors in leukemia. The dysregulation and functions of the NR4A members are due to many factors, including transcriptional regulation, protein-protein interactions, and post-translational modifications. These various levels of intracellular regulation result from the signaling cross-talk of the NR4A members with various signaling pathways, many of which are relevant to cancer and likely explain the family members' functions in oncogenesis and tumor suppression. In this review, we discuss the multiple functions of the NR4A receptors in cancer and summarize a growing body of scientific literature that describes the interconnectedness of the NR4A receptors with various oncogene and tumor suppressor pathways.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NR4A; Nuclear receptor; Nur77; Nurr1; Oncogene; Tumour suppressor

Mesh:

Substances:

Year:  2014        PMID: 25446259      PMCID: PMC4276441          DOI: 10.1016/j.cellsig.2014.11.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  164 in total

1.  Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis.

Authors:  H-Z Chen; L Li; W-J Wang; X-D Du; Q Wen; J-P He; B-X Zhao; G-D Li; W Zhou; Y Xia; Q-Y Yang; C-L Hew; Y-C Liou; Q Wu
Journal:  Oncogene       Date:  2011-10-17       Impact factor: 9.867

2.  Nur77 upregulates HIF-alpha by inhibiting pVHL-mediated degradation.

Authors:  Bu Yeon Kim; Hyungsoo Kim; Eun Jung Cho; Hong Duk Youn
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

3.  SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.

Authors:  Yan Li; Leilei Chen; Tim Hon Man Chan; Ming Liu; Kar-Lok Kong; Ji-Liang Qiu; Yan Li; Yun-Fei Yuan; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2012-09-25       Impact factor: 22.682

4.  Fusion of the EWS-related gene TAF2N to TEC in extraskeletal myxoid chondrosarcoma.

Authors:  H Sjögren; J Meis-Kindblom; L G Kindblom; P Aman; G Stenman
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

5.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

6.  The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine.

Authors:  K D Senali Abayratna Wansa; Jonathan M Harris; Grace Yan; Peter Ordentlich; George E O Muscat
Journal:  J Biol Chem       Date:  2003-04-22       Impact factor: 5.157

7.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.

Authors:  L D Mayo; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

9.  Essential role for DNA-PK-mediated phosphorylation of NR4A nuclear orphan receptors in DNA double-strand break repair.

Authors:  Michal Malewicz; Banafsheh Kadkhodaei; Nigel Kee; Nikolaos Volakakis; Ulf Hellman; Kristina Viktorsson; Chuen Yan Leung; Benjamin Chen; Rolf Lewensohn; Dik C van Gent; David J Chen; Thomas Perlmann
Journal:  Genes Dev       Date:  2011-10-01       Impact factor: 11.361

10.  Akt regulates growth by directly phosphorylating Tsc2.

Authors:  Christopher J Potter; Laura G Pedraza; Tian Xu
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

View more
  35 in total

1.  CONSERVED AND EXAPTED FUNCTIONS OF NUCLEAR RECEPTORS IN ANIMAL DEVELOPMENT.

Authors:  Shari Bodofsky; Francine Koitz; Bruce Wightman
Journal:  Nucl Receptor Res       Date:  2017

2.  Synergistic and additive effect of retinoic acid in circumventing resistance to p53 restoration.

Authors:  Connie A Larsson; Sydney M Moyer; Bin Liu; Keith A Michel; Vinod Pant; Peirong Yang; Justin Wong; Adel K El-Naggar; Ralf Krahe; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-13       Impact factor: 11.205

3.  Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy.

Authors:  Mengjie Hu; Qiang Luo; Gulimiran Alitongbieke; Shuyi Chong; Chenting Xu; Lei Xie; Xiaohui Chen; Duo Zhang; Yuqi Zhou; Zhaokai Wang; Xiaohong Ye; Lijun Cai; Fang Zhang; Huibin Chen; Fuquan Jiang; Hui Fang; Shanjun Yang; Jie Liu; Maria T Diaz-Meco; Ying Su; Hu Zhou; Jorge Moscat; Xiangzhi Lin; Xiao-Kun Zhang
Journal:  Mol Cell       Date:  2017-04-06       Impact factor: 17.970

4.  A Proposed TUSC7/miR-211/Nurr1 ceRNET Might Potentially be Disturbed by a cer-SNP rs2615499 in Breast Cancer.

Authors:  Rasoul Abdollahzadeh; Asaad Azarnezhad; Sahereh Paknahad; Yaser Mansoori; Maryam Pirhoushiaran; Khaled Kanaani; Neda Bafandeh; Davood Jafari; Javad Tavakkoly-Bazzaz
Journal:  Biochem Genet       Date:  2022-03-17       Impact factor: 1.890

5.  Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.

Authors:  Ryo Shimizu; Tomoya Muto; Kazumasa Aoyama; Kwangmin Choi; Masahiro Takeuchi; Shuhei Koide; Nagisa Hasegawa; Yusuke Isshiki; Emi Togasaki; Chika Kawajiri-Manako; Yuhei Nagao; Shokichi Tsukamoto; Shio Sakai; Yusuke Takeda; Naoya Mimura; Chikako Ohwada; Emiko Sakaida; Tohru Iseki; Daniel T Starczynowski; Atsushi Iwama; Koutaro Yokote; Chiaki Nakaseko
Journal:  Leuk Res       Date:  2016-09-26       Impact factor: 3.156

6.  Acquisition of Cancer Stem Cell-like Properties in Human Small Airway Epithelial Cells after a Long-term Exposure to Carbon Nanomaterials.

Authors:  Chayanin Kiratipaiboon; Todd A Stueckle; Rajib Ghosh; Liying W Rojanasakul; Yi Charlie Chen; Cerasela Zoica Dinu; Yon Rojanasakul
Journal:  Environ Sci Nano       Date:  2019-05-24

7.  Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1.

Authors:  Ian Mitchelle S de Vera; Pankaj K Giri; Paola Munoz-Tello; Richard Brust; Jakob Fuhrmann; Edna Matta-Camacho; Jinsai Shang; Sean Campbell; Henry D Wilson; Juan Granados; William J Gardner; Trevor P Creamer; Laura A Solt; Douglas J Kojetin
Journal:  ACS Chem Biol       Date:  2016-04-29       Impact factor: 5.100

8.  Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.

Authors:  Keshav Karki; Xi Li; Un-Ho Jin; Kumaravel Mohankumar; Mahsa Zarei; Sharon K Michelhaugh; Sandeep Mittal; Ronald Tjalkens; Stephen Safe
Journal:  J Neurooncol       Date:  2019-11-21       Impact factor: 4.130

9.  Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis.

Authors:  Boning Niu; Jie Liu; Ben Lv; Jiacheng Lin; Xin Li; Chunxiao Wu; Xiaohua Jiang; Zhiping Zeng; Xiao-Kun Zhang; Hu Zhou
Journal:  Nat Commun       Date:  2021-05-14       Impact factor: 14.919

10.  miR-20a Promotes the Axon Regeneration of DRG Neurons by Targeting Nr4a3.

Authors:  Lili Zhao; Leilei Gong; Ping Li; Jing Qin; Lingchi Xu; Qiyao Wei; Huimin Xie; Susu Mao; Bin Yu; Xiaosong Gu; Songlin Zhou
Journal:  Neurosci Bull       Date:  2021-03-08       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.